Trial Profile
Long-term Follow-up Study to Assess Antibody Persistence in Children Previously Vaccinated With Four Doses of Pneumococcal Conjugate Vaccine in Primary Vaccination Study (105553) and Booster Vaccination Study (107046)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Nov 2023
Price :
$35
*
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate
- Indications Pneumococcal infections; Streptococcal infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GlaxoSmithKline Biologicals; GSK
- 03 Apr 2013 New trial record